| 1 |
Zhang X, Ha S, Lau HC, et al. Excess body weight: Novel insights into its roles in obesity comorbidities [J]. Semin Cancer Biol, 2023, 92: 16-27.
|
| 2 |
Chooi YC, Ding C, Magkos F. The epidemiology of obesity [J]. Metabolism, 2019, 92: 6-10.
|
| 3 |
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults [J]. Lancet, 2017, 390(10113): 2627-2642.
|
| 4 |
Grill HJ. A role for GLP-1 in treating hyperphagia and obesity [J]. Endocrinology, 2020, 161(8): bqaa093.
|
| 5 |
Bassatne A, Chakhtoura M, Saad R, et al. Vitamin D supplementation in obesity and during weight loss: a review of randomized controlled trials [J]. Metabolism, 2019, 92: 193-205.
|
| 6 |
Perdomo CM, Cohen RV, Sumithran P, et al. Contemporary medical, device, and surgical therapies for obesity in adults [J]. Lancet, 2023, 401(10382): 1116-1130.
|
| 7 |
Nuzzo A, Czernichow S, Hertig A, et al. Prevention and treatment of nutritional complications after bariatric surgery [J]. Lancet Gastroenterol Hepatol, 2021, 6(3): 238-251.
|
| 8 |
Do TP, Hvedstrup J, Schytz HW. Botulinum toxin: a review of the mode of action in migraine [J]. Acta Neurol Scand, 2018, 137(5): 442-451.
|
| 9 |
陈英, 刘庆森, 郭明洲, 等. A型肉毒毒素胃壁注射对大鼠胃排空和胃肌电的影响 [J]. 胃肠病学, 2011, 16(5): 272-276.
|
| 10 |
李莉. 内镜下胃壁注射A型肉毒毒素治疗单纯性肥胖的临床研究 [D]. 军医进修学院;解放军总医院, 2010.
|
| 11 |
Rollnik JD, Meier PN, Manns MP, et al. Antral injections of botulinum a toxin for the treatment of obesity [J]. Ann Intern Med, 2003, 138(4): 359-360.
|
| 12 |
Albani G, Petroni ML, Mauro A, et al. Safety and efficacy of therapy with botulinum toxin in obesity: a pilot study [J]. J Gastroenterol, 2005, 40(8): 833-835.
|
| 13 |
Foschi D, Corsi F, Lazzaroni M, et al. Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study [J]. Int J Obes (Lond), 2007, 31(4): 707-712.
|
| 14 |
Sánchez Torralvo FJ, Vázquez Pedreño L, Gonzalo Marín M, et al. Endoscopic intragastric injection of botulinum toxin A in obese patients on bariatric surgery waiting lists: a randomised double-blind study (IntraTox study) [J]. Clin Nutr, 2021, 40(4): 1834-1842.
|
| 15 |
García-Compean D, Mendoza-Fuerte E, Martínez JA, et al. Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity. Results of a pilot study [J]. Gastroenterol Clin Biol, 2005, 29(8-9): 789-791.
|
| 16 |
Júnior AC, Savassi-Rocha PR, Coelho LG, et al. Botulinum a toxin injected into the gastric wall for the treatment of class III obesity: a pilot study [J]. Obes Surg, 2006, 16(3): 335-343.
|
| 17 |
de Moura EGH, Ribeiro IB, Frazão MSV, et al. EUS-guided intragastric injection of botulinum toxin a in the preoperative treatment of super-obese patients: a randomized clinical trial [J]. Obes Surg, 2019, 29(1): 32-39.
|
| 18 |
Bustamante F, Brunaldi VO, Bernardo WM, et al. Obesity treatment with botulinum toxin-A is not effective: a systematic review and meta-analysis [J]. Obes Surg, 2017, 27(10): 2716-2723.
|
| 19 |
Chang PC, Jhou HJ, Chen PH, et al. Intragastric botulinum toxin A injection is an effective obesity therapy for patients with BMI > 40 kg/m2: a systematic review and meta-analysis [J]. Obes Surg, 2020, 30(10): 4081-4090.
|
| 20 |
Yen YA, Wang CC, Sung WW, et al. Intragastric injection of botulinum toxin A for weight loss: A systematic review and meta-analysis of randomized controlled trials [J]. J Gastroenterol Hepatol, 2022, 37(6): 983-992.
|
| 21 |
Bang CS, Baik GH, Shin IS, et al. Effect of intragastric injection of botulinum toxin A for the treatment of obesity: a meta-analysis and meta-regression [J]. Gastrointest Endosc, 2015, 81(5): 1141-9.e1-7.
|
| 22 |
Elshakh H, El-Ejji K, Taheri S. The role of endoscopic intra-gastric botulinum toxin-A for obesity treatment [J]. Obes Surg, 2017, 27(9): 2471-2478.
|
| 23 |
Gui D, Mingrone G, Valenza V, et al. Effect of botulinum toxin antral injection on gastric emptying and weight reduction in obese patients: a pilot study [J]. Aliment Pharmacol Ther, 2006, 23(5): 675-680.
|
| 24 |
Topazian M, Camilleri M, Enders FT, et al. Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight [J]. Clin Gastroenterol Hepatol, 2013, 11(2): 145-150.e1.
|
| 25 |
Theodoridis X, Chourdakis M, Haidich AB, et al. Treatment of obesity with intragastric injection of botulinum toxin. Is it worth the pinch? An overview of systematic reviews and meta-analysis [J]. Obes Res Clin Pract, 2023, 17(3): 184-191.
|
| 26 |
Mittermair R, Keller C, Geibe lJ. Intragastric injection of botulinum toxin A for the treatment of obesity [J]. Obes Surg, 2007, 17(6): 732-736.
|
| 27 |
le Roux CW, Batterham RL, Aylwin SJ, et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety [J]. Endocrinology, 2006, 147(1): 3-8.
|
| 28 |
Steinert RE, Feinle-Bisset C, Asarian L, et al. Ghrelin, CCK, GLP-1, and PYY(3-36): secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB [J]. Physiol Rev, 2017, 97(1): 411-463.
|
| 29 |
Nimeri A, Zaman MB, Maasher A, et al. Endoscopic intra-gastric botulinum toxin injection for obesity leading to total gastrectomy and Rouxen Y esophago-jejunostomy [J]. Surg Obes Relat Dis, 2016, 12: S116.
|
| 30 |
Kılboz BB, Ervatan Z, Dumlu R, et al. Iatrogenic systemic botulism after intragastric botulinum neurotoxin injection: case report [J]. Eur J Neurol, 2023, 30(10): 3394-3396.
|
| 31 |
Hennen C, Demir S, Dafsari HS, et al. Botulism after intragastric botulinum toxin injections for weight reduction [J]. Eur J Neurol, 2023, 30(12): 3979-3981.
|
| 32 |
Chakhtoura M, Haber R, Ghezzawi M, et al. Pharmacotherapy of obesity: an update on the available medications and drugs under investigation [J]. E Clinical Medicine, 2023, 58: 101882.
|
| 33 |
Drucker DJ. Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity [J]. Diabetes Care, 2024, 47(11): 1873-1888.
|
| 34 |
Tayyem RM, Qandeel HG, Al-Balas HI, et al. Comparison of safety and efficacy of intragastric botulinum toxin-A versus gastric balloon [J]. Saudi J Gastroenterol, 2022, 28(4): 276-281.
|
| 35 |
Hill C, Khashab MA, Kalloo AN, et al. Endoluminal weight loss and metabolic therapies: current and future techniques [J]. Ann N Y Acad Sci, 2018, 1411(1): 36-52.
|
| 36 |
Özdil K, Çağatay AK, Sayar S, et al. Can gastric botulinum toxin A injection be used as minimally invasive procedure in the short-term treatment of obesity? [J]. J Minim Access Surg, 2022, 18(2): 201-206.
|
| 37 |
Wang S, Wang Y, Lin L, et al. Layer-specific BTX-A delivery to the gastric muscularis achieves effective weight control and metabolic improvement [J]. Adv Sci (Weinh), 2023, 10(28): e2300822.
|
| 38 |
Ross R, Neeland IJ, Yamashita S, et al. Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity [J]. Nat Rev Endocrinol, 2020, 16(3): 177-189.
|
| 39 |
Nimptsch K, Konigorski S, Pischon T. Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine [J]. Metabolism, 2019, 92: 61-70.
|